Ashton Thomas Private Wealth
CVS icon

Ashton Thomas Private Wealth’s CVS Health CVS Stock Holding History

Ashton Thomas Private Wealth’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.73M Sell
20,214
-5,774
-22% -$565K 0.03% 422
2026
Q2 		$2.69M Buy
25,988
+2,463
+10% +$220K 0.06% 326
2026
Q1 		$1.69M Buy
23,525
+5,187
+28% +$400K 0.04% 403
2025
Q4 		$1.46M Buy
18,338
+5,861
+47% +$462K 0.04% 392
2025
Q3 		$941K Buy
12,477
+39
+0.3% +$2.67K 0.02% 481
2025
Q2 		$858K Buy
12,438
+3,057
+33% +$200K 0.03% 453
2025
Q1 		$636K Buy
9,381
+1,615
+21% +$96.6K 0.02% 493
2024
Q4 		$349K Sell
7,766
-8,483
-52% -$476K 0.01% 601
2024
Q3 		$1.02M Sell
16,249
-6,132
-27% -$358K 0.05% 307
2024
Q2 		$1.32M Sell
22,381
-10,857
-33% -$679K 0.07% 260
2024
Q1 		$2.65M Sell
33,238
-1,997
-6% -$153K 0.15% 168
2023
Q4 		$2.78M Sell
35,235
-2,348
-6% -$167K 0.17% 156
2023
Q3 		$2.62M Buy
37,583
+347
+0.9% +$24.6K 0.19% 145
2023
Q2 		$2.57M Sell
37,236
-6,345
-15% -$451K 0.2% 140
2023
Q1 		$3.24M Buy
43,581
+8,574
+24% +$719K 0.28% 94
2022
Q4 		$3.26M Sell
35,007
-8,884
-20% -$857K 0.32% 83
2022
Q3 		$4.19M Buy
43,891
+1,507
+4% +$149K 0.47% 47
2022
Q2 		$3.93M Buy
42,384
+11,240
+36% +$1.1M 0.42% 61
2022
Q1 		$3.15M Buy
31,144
+6,334
+26% +$665K 0.28% 100
2021
Q4 		$2.56M Sell
24,810
-4,198
-14% -$388K 0.25% 104
2021
Q3 		$2.46M Buy
29,008
+3,068
+12% +$257K 0.36% 72
2021
Q2 		$2.16M Buy
25,940
+494
+2% +$40.5K 0.33% 81
2021
Q1 		$1.91M Sell
25,446
-147
-0.6% -$10.7K 0.32% 77
2020
Q4 		$1.75M Buy
25,593
+964
+4% +$62.7K 0.33% 81
2020
Q3 		$1.44M Buy
24,629
+10,901
+79% +$678K 0.36% 74
2020
Q2 		$892K Sell
13,728
-57
-0.4% -$3.59K 0.26% 101
2020
Q1 		$818K Buy
13,785
+1,828
+15% +$122K 0.33% 87
2019
Q4 		$888K Buy
+11,957
New +$840K 0.29% 94

Other funds holding CVS

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Ashton Thomas Private Wealth's CVS Position: Q3 2026 in Review

Ashton Thomas Private Wealth reduced its CVS Health (CVS) stake by 22% in Q3 2026, selling an estimated $565K and leaving 20,214 shares worth $1.73M. The position accounts for 0.03% of the portfolio, ranked #422.

Ashton Thomas Private Wealth first reported a position in CVS in Q4 2019 and has held it in 28 quarters since. The position peaked at $4.19M in Q3 2022. 1,724 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Ashton Thomas Private Wealth held 20,214 shares of CVS Health worth $1.73M as of Q3 2026.
  • Ashton Thomas Private Wealth sold 5,774 CVS Health shares in Q3 2026, an estimated $565K.
  • CVS Health made up 0.03% of Ashton Thomas Private Wealth's portfolio in Q3 2026, its #422 holding.
  • Ashton Thomas Private Wealth first reported a position in CVS Health in Q4 2019 and has held it in 28 quarters since.
  • Ashton Thomas Private Wealth's CVS Health position peaked at $4.19M in Q3 2022.
  • 1,724 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.